Arthur Kavanaugh

Aug 2, 2024 | acrjournals.onlinelibrary.wiley.com | Arthur Kavanaugh |Philip Mease |Laure Gossec

INTRODUCTION Psoriatic arthritis (PsA) is a heterogeneous condition associated with a high disease burden and significant comorbidities.1 The primary treatment goal in PsA is to maximize health-related quality of life (QoL) by achieving the lowest possible level of disease activity, managing symptoms, and preventing irreversible joint damage and disability.1, 2 Disease activity and its control in PsA can be assessed using a variety of measures, including minimal disease activity (MDA) and...

Mar 1, 2024 | rmdopen.bmj.com | Peter Taylor |Arthur Kavanaugh |Peter Nash |Janet Pope

Impact of filgotinib on pain control in the phase 3 FINCH studies Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Feb 29, 2024 | healio.com | John J. Cush |Michael E Weinblatt |Arthur Kavanaugh

IntroductionThe discovery and introduction of corticosteroid therapy by Philip Hench in the late 1940s and early 1950s was a seminal advance in the treatment of inflammatory diseases, including rheumatoid arthritis (RA). Prior to the introduction of steroids, RA therapy was dominated by poorly effective and toxic therapies (aspirin and gold salts). The glucocorticoid compounds became well known for their impressive and rapid clinical efficacy in a variety of inflammatory clinical disorders.

May 25, 2023 | onlinelibrary.wiley.com | Ying-Ying Leung |Arthur Kavanaugh |Christopher T. Ritchlin

Treatment history TNFi treatments can be highly effective across all PsA domains, yet some patients demonstrate a primary inadequate response or no improvement with a TNFi, whereas others experience a secondary inadequate response with initial improvement followed by a gradual return of symptoms and fatigue or a frank disease flare.

Mar 28, 2023 | medscape.com | Stanley Cohen |Arthur Kavanaugh

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Stanley Cohen, MD: Hello. I'm Dr Stan Cohen. Welcome to Medscape's InDiscussion series on psoriatic arthritis. It's my pleasure to have one of my old friends and colleagues with us today, Dr Arthur Kavanaugh.